Etoricoxib (ETR) is a non-ionizable BCS class II drug with no typical hydrogen bond donors
and low solubility in water. Cocrystal was proved to be a good strategy to improve …

Novel crystalline forms of etoricoxib (ETR) with pharmaceutically acceptable coformers
(generally regarded as safe, GRAS), such as glutaric acid (1: 1), adipic acid (2: 1), suberic …

Polymorphic forms of etoricoxib have been reported in the literature, and form I was
considered to be the most stable one. However, in this work, it was found that form I and form …

In this paper, a comprehensive study of the solid and solution chemistry of etoricoxib (ETR)
was conducted through the combined experimental identification and theoretical calculation …

Ezetimibe (EZT) being an anticholesterol drug is frequently used for the reduction of
elevated blood cholesterol levels. With the purpose of improving the physicochemical …

Crystalline hydrates and propylene glycol solvates of celecoxib sodium salt (Cel-Na) were
prepared and characterized with the aim of improving oral drug absorption by breaking up …

The objectives of the study were to screen and prepare cocrystals of anti-cholesterol drug
ezetimibe (EZT) with the aim of increasing its solubility and dissolution rate. Thermodynamic …

Three co-crystals of celecoxib (CEL) and bipyridine derivatives were synthesized based on
the synthon design approach and structurally characterized. The resulting two-component …

Tenoxicam (TNX) belongs to the oxicam family of drugs popularly known as nonsteroidal
anti-inflammatory drugs (NSAIDs). Its therapeutic action as a drug is limited by poor aqueous …

The prevalence of poor solubility in active pharmaceutical ingredients (APIs) such as
celecoxib (CEL) is a major bottleneck in the pharmaceutical industry, leading to a low …